Connected medical devices have become ordinary features of hospital care. Infusion pumps, patient monitors, imaging systems, laboratory analysers and specialist diagnostic equipment increasingly run on software and exchange data across hospital networks. That connectivity supports safer monitoring, faster results and more coordinated care. It also expands the attack surface well beyond the traditional IT estate, into equipment that clinicians depend on at the bedside and in critical departments.
The consequence is a shift in where cybersecurity responsibility sits. Device security is no longer only a matter for IT departments or specialist security teams. It is becoming a procurement and lifecycle governance issue, because many of the controls that determine whether a device can be secured are fixed before it enters the hospital. Contracts, supplier commitments, asset records and replacement planning all shape the risk long after a purchase decision is made. The 2026 Global Healthcare Awards’ focus on practical innovation, safety and accountable delivery reflects this operating reality: credible progress depends less on a single security product than on disciplined governance across clinical, technical and supply-chain functions.
A Governance Problem, Not an IT Problem
Medical devices are difficult to secure because they are not general-purpose computers. They often run embedded software, use proprietary operating systems and cannot easily accept standard security agents. Vendors may restrict access to the underlying system, and clinical teams may be reluctant to interrupt equipment for updates. Devices may also be purchased by clinical departments rather than central IT, leaving security teams with limited visibility into what is installed and where.
That fragmentation makes joint governance essential. Clinical engineering understands device operation, maintenance and clinical dependency. IT security understands network exposure, vulnerability management and threat detection. Supply chain and procurement teams control contracts, purchasing decisions and supplier relationships. When these groups work separately, gaps appear: a device may be approved clinically without a security review, connected to the network without a full inventory record, or left unpatched because no one has agreed who is responsible.
A more effective model treats device security as a shared operating responsibility. Clinical engineering can act as the device owner’s technical partner, IT security can set network and monitoring requirements, and procurement can translate those requirements into contractual terms. Clinical leaders remain responsible for decisions about acceptable risk when a device is isolated, updated or replaced. The goal is not to eliminate all risk, which is unrealistic for complex clinical equipment, but to make risk visible and assign accountability for managing it.
Procurement Contracts as Control Points
Procurement is one of the few moments when a hospital has real leverage over a supplier. Contracts can require security by design rather than treating security as an optional add-on. At a minimum, buyers can ask suppliers to describe how the device is hardened, how vulnerabilities are disclosed, how often software is updated and how long support will last. These questions are more useful when they are written into agreements rather than left to informal assurances.
Several contract terms are becoming practical necessities. A software bill of materials can give hospitals visibility into third-party components and help them assess exposure when a widely used library or operating system component is found to be vulnerable. Vulnerability disclosure commitments establish how and when a supplier will notify customers about security issues. Patching timelines clarify expectations for critical and non-critical fixes. End-of-support commitments help hospitals plan replacement rather than discovering too late that a device will no longer receive security updates.
Contracts can also address secure configuration, remote support access, incident notification and cooperation during an investigation. Not every device carries the same risk, so requirements can be tiered according to clinical criticality and network exposure. A networked infusion device in a critical care unit may warrant different terms from a stand-alone device in a back office. The important point is that security expectations are documented before purchase and carried through the device lifecycle, including maintenance renewals and service agreements.
The Inventory Is the Foundation
None of these controls works without a maintained asset inventory. Hospitals need to know which device models are in use, which software and firmware versions they run, where they are connected and who owns them clinically. That record should include network connections, supported operating systems, supplier contacts and support status. It should also identify devices approaching end of support or those that cannot be patched.
Many hospitals have partial inventories held in different systems, but device security requires a living record rather than a one-off audit. Network discovery tools can help identify connected equipment, but they do not replace clinical engineering knowledge or supplier data. Procurement can reinforce inventory discipline by requiring device information in a usable format at purchase and by making updates part of supplier obligations. When an incident occurs, an accurate inventory allows a hospital to locate affected devices, assess clinical dependencies and decide quickly whether to isolate, patch or replace equipment.
Incident Response and Legacy Planning
Incident-response plans for medical devices must account for the clinical consequences of security actions. Isolating a device or taking it offline may be the correct technical step, but it can also interrupt monitoring, delay results or force staff onto manual procedures. Plans therefore need input from clinical engineering, clinical leaders and suppliers, not only from IT security. They should identify degraded operating procedures, alternative equipment, escalation routes and communication steps for frontline staff.
Legacy and unpatched devices present a harder problem. Some cannot be updated because the supplier no longer supports them or because the clinical software is tightly coupled to an old operating system. Ad hoc workarounds are rarely sufficient. Hospitals need compensating controls, such as network segmentation, restricted access and closer monitoring, alongside a funded replacement plan. That planning belongs in capital and procurement cycles, where end-of-support dates and lifecycle costs can be considered before a device becomes an urgent risk.
Conclusion: An Operating Discipline
Medical device cybersecurity is becoming a test of how hospitals buy, maintain and govern the technology they use. Security-by-design, software bills of materials, patching commitments, accurate inventories and incident-response planning are not separate technical exercises. They are parts of one lifecycle discipline that connects procurement, clinical engineering, IT security and frontline care.
The 2026 Global Healthcare Awards’ interest in practical innovation, safety and accountable delivery aligns with that discipline. The most credible progress is unlikely to come from a single tool or a one-off audit. It will come from hospitals that write security into contracts, maintain visibility over connected devices and plan for the clinical effects of disruption. In that sense, procurement is not simply a purchasing function. It is one of the primary control points for protecting care in an increasingly connected clinical environment.
